Safety Information

Description Publish Date LINKS
Important safety information on Dolutegravir in Lebanon
10/10/2018

Important safety information on Lamotrigine in Lebanon
10/10/2018
Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck 15/02/2024
Important safety information on Non-steroidal anti-inflammatory drugs (NSAlDs) in Lebanon 11/06/2021

Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Lebanon

09/09/2023
Important safety information on Dolutegravir in Lebanon (Safety Notification_Korean label update for Dolutegravir containing products) 01-11-2023
Important safety information on Paroxetine in Lebanon (Safety Notification_EMA communication issued relating to Paroxetine label update) 27-10-2023
Important safety information on Sumatriptan in Lebanon (Safety Notification_Sumatriptan and breast pain) 07-11-2023
Important safety information on Topical Corticosteroids containing products in Lebanon 15-11-2023
Important safety information on Hepatitis B surface antigen recombinant vaccine in Lebanon (Initial Safety Notification Engerix-B and Myelitis_November 2023) 17-11-2023
Important safety information on Hepatitis B surface antigen recombinant vaccine in Lebanon (Updated Safety Notification Engerix-B and Myelitis_December 2023) 02-01-2024